Skip to main content


Novartis Reportedly Preps Sale Process for U.S. Generic Pill Business

The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.

Impax Shares Jump on Merger Buzz

Impax's shares soar after the Wall Street Journal reported that the drug maker is in merger discussions with Amneal Pharmaceuticals.

Impax Shares Jump After Chinese Firm Reveals 5% Stake

Shanghai Fosun Pharmaceutical owns 3.85 million shares, according to a 13G filing.

Teva, Mylan Seen to Stay on M&A Sidelines

Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila.

Teva's Post Earnings Selloff Triggers Oppenheimer, Fitch Downgrades

It is just not going to get better anytime soon.

Breaking News

Elon Musk and Tesla Set Their Sights on a Popular Industry

The electric vehicle manufacturer has a very popular industry in its sights despite often low margins.

New Trader Joe's Popcorn Just Dropped

Here's why people are freaking out about the latest Trader treat.

Tank Tips: Best Gas Saving Moves for Memorial Day

Cut costs with these Memorial Day gasoline-saving tips

Luxury-Home Builder Toll Brothers Beats Q2 Profit, Revenue Estimates

Toll Brothers earned $1.85 a share in its fiscal second quarter on 18% higher revenue.